EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care

Lile Xiong iD, Xiufen Yang, Hua Yuan, Lan Qin, Binghu Lin, Fengjiao Chen, Yi Wen iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s587428 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Lile Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shenzhen People's Hospital, Shenzhen, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Design, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungDrug DesignProtein Kinase InhibitorsAntineoplastic AgentsPainHumansErbB ReceptorsMutationNeoplasm, ResidualMolecular Targeted Therapy

Stichwörter der Autor:innen

EGFR-mutated NSCLCfourth-generation EGFR-TKIpain managementpatient-reported outcomesperioperative targeted therapy

Substanzen

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Shenzhen People's Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Department of Emergency, Shenzhen People's Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Department of Nursing, Shenzhen People's Hospital, Shenzhen, Guangdong, People's Republic of China.

ORCID-Profile: Lile Xiong, Yi Wen

Zitieren

APA

Xiong, L., Yang, X., Yuan, H., Qin, L., Lin, B., Chen, F., & Wen, Y. (2026). Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s587428

Vancouver

Xiong L, Yang X, Yuan H, Qin L, Lin B, Chen F, et al. Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s587428

BibTeX
@article{Xiong2026,
  author = {Xiong, Lile and Yang, Xiufen and Yuan, Hua and Qin, Lan and Lin, Binghu and Chen, Fengjiao and Wen, Yi},
  title = {Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s587428}
}
Kostenlos starten →